Figures & data
Table 1. Overview of quiescent stem cells characterized to date.
Table 2. Overview of quiescent cancer stem cells characterized to date.
Cotsarelis G, Cheng SZ, Dong G, Sun TT, and Lavker Rm (1989). Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 57: 201–209. Cotsarelis G, Sun TT, and Lavker RM (1990). Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 61:1329–1337. Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, and Cotsarelis G (1998). The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci. 111 (Pt 21): 3179–3188. Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, and Cotsarelis G (1999). Human hair follicle bulge cells are biochemically distinct and possess an epithelial stem cell phenotype. J Investig Dermatol Symp Proc. 4: 296–301. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, and Fuchs E (2004). Defining the epithelial stem cell niche in skin. Science. 303: 359–63. Wilson A, Laurenti E, Oser G, Van Der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E, Lio P, Macdonald HR, and TRUMPP A (2008). Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 135: 1118–29. Foudi A, Hochedlinger K, Van Buren D, Schindler Jw, Jaenisch R, Carey V, and Hock H (2009). Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat Biotechnol. 27: 84–90. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, and Goodell MA (2002). Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 245: 42–56. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, and Visvader JE (2006). Generation of a functional mammary gland from a single stem cell. Nature. 439: 84–88. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG, and Di Fiore PP (2010). Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 140: 62–73. Morshead Cm, Reynolds BA, Craig CG, Mcburney MW, Staines Wa, Morassutti D, Weiss S, And Van Der Kooy D (1994). Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron. 13: 1071–1082. Teng C, Guo Y, Zhang H, Zhang H, Ding M, and Deng H (2007). Identification and characterization of label-retaining cells in mouse pancreas. Differentiation. 75: 702–12. Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, Moscatelli D, Shapiro E, Lepor H, Sun TT, and Wilson EL (2002). Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol. 157: 1257–65. Potten CS (1998). Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci. 353: 821–830. Potten CS, Booth C, Tudor GI, Booth D, Brady G, Hurley P, Ashton G, Clarke R, Sakakibara S-I, and Okano H (2003). Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation. 71: 28–41. Nishimura S, Wakabayashi N, Toyoda K, Kashima K, and Mitsufuji S (2003). Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci. 48: 1523–1529. May R, Riehl TE, Hunt C, Sureban SM, Anant S, and Houchen CW (2008) Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells, 26:630–637. May R, Sureban SM, Hoang N, Riehl Te, Lightfoot SA, Ramanujam R, Wyche JH, Anant S, and Houchen CW (2009). Dcamkl-1 and LGR5 Mark Quiescent and Cycling Intestinal Stem Cells Respectively. Stem Cells, 10: 2571–2579. Sangiorgi E and Capecchi MR (2008). Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet. 40: 915–920. Breault Dt, Min IM, Carlone DL, Farilla LG, Ambruzs Dm, Henderson De, Algra S, Montgomery RK, Wagers AJ, and Hole N (2008). Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proc Natl Acad Sci U S A. 105: 10420–10425. Montgomery RK, Carlone DI, Richmond CA, Farilla L, Kranendonk Me, Henderson DE, Baffour-Awuah NY, Ambruzs DM, Fogli Lk, Algra S, and Breault Dt (2011). Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A. 108: 179–184. Roth S, Franken PF, Sacchetti A, and Fodde R (2011). Identification of quiescent and multipotent intestinal Paneth-like cells that are activated in response to tissue injury. submitted. Qiao XT, Ziel JW, Mckimpson W, Madison BB, Todisco A, Merchant JL, Samuelson LC, and Gumucio DL (2007). Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology. 133: 1989–1998. Kusumbe AP and Bapat SA (2009). Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res. 69: 9245–53. Gao MQ, Choi YP, Kang S, Youn JH, and Cho NH (2010). CD24 + cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene. 29: 2672–2680. Dembinski Jl And Krauss S (2009). Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastasis. 26: 611–623. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, and Herlyn M (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 141: 583–594. Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, and Mori M (2010). CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest. 120: 3326–3339. Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, Najima Y, Takagi S, Aoki Y, Wake A, Taniguchi S, Shultz LD, and Ishikawa F (2010). Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol. 28: 275–280.